Oct 9
|
MannKind Corp (MNKD) Q2 2024 Earnings Call Highlights: Record Revenue and Strategic Pipeline ...
|
Oct 9
|
Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
|
Oct 7
|
Why MannKind (MNKD) Could Beat Earnings Estimates Again
|
Sep 30
|
More Adults With Type 1 Diabetes Achieved A1C Goal (<7%) After Switching From Multiple Daily Insulin Injections or Automated Pumps to Inhaled Insulin (Afrezza®)
|
Jul 17
|
Is There An Opportunity With MannKind Corporation's (NASDAQ:MNKD) 49% Undervaluation?
|
Jul 16
|
All You Need to Know About MannKind (MNKD) Rating Upgrade to Buy
|
Jul 16
|
Is MannKind (MNKD) Outperforming Other Medical Stocks This Year?
|
Jul 16
|
MannKind Corporation (MNKD) Hit a 52 Week High, Can the Run Continue?
|
Jun 22
|
INHALE-3 Study Reveals Positive Readout in Head-to-Head Comparison of Inhaled Insulin vs. Usual Care in T1D; New Data Presented at American Diabetes Association’s 84th Scientific Sessions
|
Jun 20
|
Recent 5.2% pullback isn't enough to hurt long-term MannKind (NASDAQ:MNKD) shareholders, they're still up 327% over 5 years
|
May 13
|
MannKind (MNKD) Upgraded to Strong Buy: Here's Why
|
May 10
|
MannKind First Quarter 2024 Earnings: Beats Expectations
|
May 10
|
MannKind Corp (MNKD) Q1 2024 Earnings Call Transcript Highlights: A Quarter of Robust Growth ...
|
May 9
|
MannKind Corporation (NASDAQ:MNKD) Q1 2024 Earnings Call Transcript
|
May 9
|
Shareholders May Not Be So Generous With MannKind Corporation's (NASDAQ:MNKD) CEO Compensation And Here's Why
|
May 9
|
MannKind (MNKD) Q1 2024 Earnings Call Transcript
|
May 8
|
Compared to Estimates, MannKind (MNKD) Q1 Earnings: A Look at Key Metrics
|
May 8
|
MannKind (MNKD) Beats Q1 Earnings and Revenue Estimates
|
May 8
|
MannKind Corporation Reports 2024 First Quarter Financial Results: Provides Clinical Development Update
|
May 6
|
MannKind Receives U.S. FDA Fast Track Designation for Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease
|